Obstetric implications of antepartum corticosteroid therapy for hellp syndrome

Obstetrics and Gynecology

Volumn 104, Issue 5, 2004, Pages 1011-1014

  Rose, Carl H ^a   Thigpen, Brad D ^a   Bofill, James A ^a   Cushman, Julie ^a   May, Warren L ^a   Martin, James N ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETAMETHASONE; CORTICOSTEROID; LACTATE DEHYDROGENASE; LIVER ENZYME;

ARTICLE; FEMALE; HELLP SYNDROME; HUMAN; LABOR INDUCTION; OBSTETRIC ANESTHESIA; PREGNANCY; PREGNANCY OUTCOME; REGIONAL ANESTHESIA; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; ADULT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; VAGINAL DELIVERY;

ANESTHESIA, CONDUCTION; ANESTHESIA, OBSTETRICAL; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HELLP SYNDROME; HUMANS; LABOR, INDUCED; PLATELET COUNT; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 16244367744     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000143262.85124.e8     Document Type: Article

References (14)

1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-67.
2. Magann EF, Roberts WE, Perry KG, Chauhan SP, Blake PG, Martin JN Jr. Factors relevant to mode of preterm delivery with syndrome of HELLP (hemolysis, elevated liver enzymes, and low platelets). Am J Obstet Gynecol 1994;170:1828-34.
3. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN Jr. Antepartum corticosteroids: disease stabilization in patients with HELLP syndrome. Am J Obstet Gynecol 1994;171:1148-53.
4. Martin JN Jr., Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180:1373-84.
5. Martin JN, Thigpen BD, Rose CH, Cushman J, Moore A, May WL. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 2003;189:830-4.
6. Martin JN Jr, Magann EF, Isler CM. HELLP syndrome: the scope of disease and treatment. Hypertens Pregnancy 2003;141-88.
7. Rayburn WF. Preinduction cervical ripening: basis and methods of current practice. Obstet Gynecol Survey 2002;57:683-92.
8. Gutsche BB, Cheek TG. Anesthetic considerations in preeclampsia-eclampsia. In: Shnider, Levinson, editors. Anesthesia for obstetrics. 3rd ed. Philadelphia (PA): Lippincott Williams and Wilkins; 1993. p. 305-36.
9. Gaiser RR, Gutsche BB, Cheek TG. Anesthetic considerations for the hypertensive disorders of pregnancy. In: Shnider SM, Levinson G, editors. Anesthesia for obstetrics. 4th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2002. p. 297-322.
10. Foley LS. Anesthetic management of hypertension in pregnancy. Clin Obstet Gynecol 2003;46:688-99.
11. Rasmus KT, Rottman RL, Kotelko DM, Wright WC, Stone JJ, Rosenblatt RM. Unrecognized thrombocytopenia and regional anesthesia in parturients: a retrospective review. Obstet Gynecol 1989;73:943-6.
12. −3. Anesth Analg 1997;85:385-8.
13. Obstetric analgesia and anesthesia. ACOG Practice Bulletin No. 36. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:177-91.
14. O'Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol 2002;186:475-9.